What is the current Amgen Inc (AMGN) share price?

Amgen Inc last traded at $352.82 with a market capitalisation of about $190.4B.

What is the analyst price target for AMGN?

The mean analyst price target for Amgen Inc is $352.77, roughly 0.0% below the latest price. The current consensus rating is “Buy”.

Is AMGN expensive on a P/E basis?

Amgen Inc currently trades on a price-to-earnings ratio of 102.3, with a price-to-book of 20.2.

Where can I see Amgen Inc's full financial metrics?

Luminoso tracks AMGN's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.

Amgen Inc (AMGN) Stock Forecast

US · Healthcare

Current price

$352.82

Market cap

$190.42B

Mean price target

$352.77

Implied upside

-0.0%

Key takeaways

Analysts rate Amgen Inc a “Buy”, with a mean price target of $352.77 — about 0.0% downside from the current $352.82, based on 30 analysts.
AMGN is trading in the middle of its 52-week range, at 68% of the $269.77–$391.29 band.
On valuation, AMGN trades at a premium P/E of 102.3 and an EV/EBITDA of 60.0.
Profitability looks respectable: return on equity is 19.8%, with a free-cash-flow margin of 17.1%.
Its balance sheet looks adequate, with a current ratio of 1.26. Net debt/EBITDA stands at 11.7x.

Analyst consensus

Consensus rating	Buy
Number of analysts	30
Mean target	$352.77
High target	$427.00
Low target	$200.00
Rating split (SB / B / H / S / SS)	4 / 9 / 18 / 2 / 1

Price & trading

Current price	$352.82
Previous close	$351.39
52-week high	$391.29
52-week low	$269.77
50-day average	$339.99
Beta	0.42

Valuation

P/E ratio	102.29
P/B ratio	20.24
EV / EBITDA	59.98
Dividend yield	0.0%
Revenue per share	$15.97
Book value per share	$17.03

Profitability

Return on equity (ROE)	19.8%
Return on assets (ROA)	2.0%
Return on invested capital (ROIC)	4.4%
Free-cash-flow margin	17.1%
FCF yield	0.8%

Financial health

Current ratio	1.26
Quick ratio	1.01
Debt / equity	9.07
Net debt / EBITDA	11.74
Interest coverage	4.17
Altman Z-score	1.24

See the full AMGN breakdown on Luminoso

Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.

Start free — 2 months on us

Frequently asked questions

What is the current Amgen Inc (AMGN) share price?: Amgen Inc last traded at $352.82 with a market capitalisation of about $190.4B.
What is the analyst price target for AMGN?: The mean analyst price target for Amgen Inc is $352.77, roughly 0.0% below the latest price. The current consensus rating is “Buy”.
Is AMGN expensive on a P/E basis?: Amgen Inc currently trades on a price-to-earnings ratio of 102.3, with a price-to-book of 20.2.
Where can I see Amgen Inc's full financial metrics?: Luminoso tracks AMGN's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.

More stocks

Browse all companies covered by Luminoso →

Last updated 25 Jun 2026.

Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.